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EFFECT OF TYPE 2 DIABETES ON THE ABILITY OF B AND T LYMPHOCYTES 
TO STIMULATE OSTEOCLASTOGENESIS/OSTEOCLASTIC ACTIVITY IN VITRO 
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Boston University, Henry M. Goldman School of Dental Medicine, 2019 
Major Professor: Dr. Barbara Nikolajczyk, Associate Professor of Pharmacology and 
Nutritional Sciences, University of Kentucky 
ABSTRACT 
Background 
Alveolar bone resorption is more severe in type 2 diabetes-potentiated 
periodontitis. The key cells responsible for bone resorption are the osteoclast and their 
quantity and activity are regulated by the RANK/RANKL/OPG system. One of the major 
RANKL-expressing sources in diseased periodontal tissue are activated B and T 
lymphocytes, therefore it was hypothesized that type 2 diabetes up-regulates B cell 
RANKL function.  
Objective 
The aim of this study was to compare the effect of diabetes on the ability of B and 
T lymphocytes to stimulate osteoclast activity.  
Materials and Methods 
Metabolic status (diabetic vs normal) of mice were established using either a low-
fat diet (LFD) or high-fat diet (HFD). Spleen lymphocytes were harvested and purified, 
then cultured in different combinations with adherent mouse leukemic 
monocyte/macrophage cell line cells over dentin-coated wells and observed for 
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osteoclastic activity that breaks down the dentin-coating. The area of clearance was used 
to represent the level of activity.  
Results 
No difference in osteoclastic activity were noted between the two metabolic 
statuses, between B or T cells, between lymphocyte stimulated or not.  
Conclusion 
The findings counters our hypothesis, and are inconsistent with the currently 
available evidence. Repeat of the experiment is warranted before valid conclusion can be 
drawn from the data. 
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INTRODUCTION 
Periodontitis is a microbially-associated, host-mediated inflammatory disease 
characterized by loss of periodontal attachment, periodontal pocket formation, and 
alveolar bone resorption, followed ultimately by tooth loss [1, 2]. Although periodontitis 
is a highly prevalent disease that affects approximately 46% of the US adult population, 
understanding of the exact pathogenesis continues to be updated [3]. Current evidence 
supports the presence of bacterial biofilm, or dental plaque, along the root surface, which 
initiates gingival inflammation [2]. Overall disease manifestation and progression are 
further determined by the immune response to the bacterial complexes in the biofilm [4]. 
In some patients, the disease may remain confined to the gingival tissue or be slowly 
progressing and thus does not endanger tooth stability. On the other hand, the disease 
progresses in susceptible patients in whom host mechanistic pathways that were 
originally programmed to protect against the microbial challenge spiral into an 
uncontrolled catabolic process [5]. Host-derived enzymes capable of destroying 
periodontal attachment apparatus become activated, which subsequently results in apical 
migration of the junctional epithelium, i.e. periodontal pocket formation, and allows 
further apical spread of the bacterial biofilm along the root surface, advancing disease 
severity [2, 3]. 
Severity of periodontitis is measured as clinical attachment loss or radiographic 
bone loss [6]. Gingivitis is the mildest and entirely reversible form of periodontal disease. 
While signs of gingivitis is almost ubiquitous in all populations, and a minor loss of 
periodontal tissue support is frequent in adults, between 5-15% of the global population 
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suffers severe forms of periodontitis [6]. According to the American Academy of 
Periodontology, a variety of factors can influence the wide spectrum of periodontal 
disease severity, including genetic susceptibility, social habits, home care, medications, 
and more. Among these, diabetes mellitus has been recognized as a bona fide risk factor 
[7]. Individuals with diabetes are more likely to be affected by higher severity and extent 
of periodontitis at an earlier age, and experience smaller degrees of improvements 
following treatment and higher rates of tooth loss [8]. 
Diabetes mellitus is a common metabolic disease with 6.4% or 285 million adults 
afflicted globally. Prevalence and incidence are expected to continue rising in the coming 
decades [9, 10]. This disease, commonly called type 2 diabetes, is characterized by 
impaired glucose homeostasis resulting from defects in insulin secretion and/or insulin 
action [11]. In poorly managed diabetes, hyperglycemia predisposes patients to a range of 
complications, including retinopathy, nephropathy, neuropathy, macrovascular diseases 
and poor wound healing [12]. Consistent evidence shows that diabetes acts as a 
modifying factor for periodontal disease [4], particularly in people with poor glycemic 
control [13]. Individuals with diabetes develop an earlier and stronger gingival 
inflammatory response than do those without diabetes, and these affected individuals 
experience greater severity of periodontitis [4, 14].  
There are several proposed mechanisms for the role of diabetes in periodontal 
disease and these can be considered as alterations in the vascular, cellular, and repair 
processes of the host. However, the exact mechanisms underlying the relationship 
between periodontitis and type 2 diabetes remains unclear. 
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One demonstrated link between periodontitis and type 2 diabetes is altered B cell 
functions [15, 16]. It has recently been shown that type 2 diabetes-associated changes in 
B cells are required for the osteoclastogenesis and pathologic bone resorption in a 
pathogen-induced periodontitis mice model [17]. Furthermore, under the same 
experimental condition, T cells cannot drive the alveolar bone loss in the absence of B 
cells [17]. These findings are consistent with a model in which B cells play both direct 
and indirect roles in type 2 diabetes-potentiated periodontitis, particularly in the 
resorption of bone. 
Bone is a dynamic and active tissue that is constantly undergoing renewal in 
response to mechanical, nutritional, and hormonal influences hormonal influences [18]. 
Under physiologic conditions, there is a balance between the carefully regulated and 
coupled processes of bone resorption by osteoclasts and bone formation by osteoblasts 
[19]. As osteoclasts are the prime bone resorptive cells, their activity is the determinant 
for alveolar bone loss.  The rate of bone resorption is regulated at the level of 
differentiation of osteoclasts from their hematopoietic precursors [18, 20, 21]. The 
activation and differentiation of osteoclasts are regulated by three members of the TNF 
ligand and receptor superfamilies: RANKL (Receptor Activator of Nuclear Kappa-B 
Ligand), RANK, and Osteoprotegerin (OPG) [18]. RANKL (redundancy deleted), binds 
to its receptor RANK on osteoclast or pre-osteoclast cell surfaces to promote proliferation 
and differentiation [1].  
Given that RANKL determines the rate of osteoclastogenesis and thereby the rate 
of bone resorption, higher level of RANKL may be associated with higher severity of 
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periodontitis according to numerous recent studies. RANKL-expressing sites had deeper 
periodontal pockets compared with the RANKL-negative sites [22]. Conversely, sites of 
advanced periodontitis have the highest level of RANKL mRNA, expressed mainly in 
lymphocytes and macrophages, compared to healthy or less severe periodontitis [23]. . 
These results suggested that enhanced immune cell RANKL production (“might be” is 
redundant) associated with alveolar bone resorption. Moreover, not only is RANKL 
upregulated, the decoy receptor that inhibits RANKL activity, OPG, is also down-
regulated in periodontitis tissue [24]. The higher RANKL:OPG ratio favors bone 
resorption.  This ratio has been reported to be further upregulated in smokers and 
diabetics [25], consistent with the observation that in type 2 diabetes-potentiated 
periodontitis, the alveolar bone loss is more severe.  
Finally, given that 1. Activated B and T lymphocytes are one of the major 
RANKL-expressing sources in diseased periodontal tissue [1] [24]; 2. Alveolar bone loss 
is more severe in type 2 diabetes-potentiated periodontitis; and 3. B cells play critical 
roles in periodontitis, I hypothesized that type 2 diabetes up-regulates B cell RANKL 
function, which uniquely potentiates periodontal complications of type 2 diabetes (Figure 
1) through mechanisms that are alternatively independent and dependent on T cell. The 
long-term goals of the Nikolajczyk lab is to define the mechanisms that potentiate 
periodontitis in type 2 diabetes and to use this knowledge to develop new methods to 
control inflammatory type 2 diabetes complications. Within this scope, the specific goal 
of my thesis was to study the effect of diabetes on the ability of B and T lymphocytes to 
stimulate osteoclast activity.   
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Figure 1. Model of B cell function in type 2 diabetes potentiated periodontitis 
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METHODS 
Animal model with fat-induced diabetes 
Five-week old male mice (DIO-B6-M; C57BL/6J) were used as the model animal. 
Two metabolic status groups were established via control of fat content in diet for a total 
of sixteen weeks: 1. HFD (High Fat Diet) group, consisting of mice fed ad libitum with 
chow where 60% of calories were from fat (Research Diets D12492i); 2. LFD (Low Fat 
Diet) group, consisting of mice fed ad libitum with chow where 10% of calories from fat 
(Research Diets). Metabolic measurements were performed on the 9th week and 15th week 
of diet and included intra-peritoneal glucose tolerance tests (IPGTT). Blood glucose 
levels were measured by glucometer by scoring the tip of the tail and measuring at 0, 10, 
20, 30, 60, 90, and 120 minutes. The body weight of mice was measured weekly and just 
prior to sacrifice at 16th week (or 21 weeks of age). 
 
Preparation of Splenocytes 
Animals were sacrificed by CO2 narcosis and skin was sterilized with 70% 
alcohol. An incision was made on the left abdomen to expose the abdominal cavity. The 
spleen was harvested and placed in RPMI medium 1640 (Gibco Life Technologies). 
The specimen was minced using the plunger end of a syringe through a 70-µm 
cell strainer submerged in RPMI medium in a 3-cm petri dish. The mixture was 
transferred to a 15ml conical tube and centrifuged at 1,200 rpm for 10 minutes. The 
supernatant was removed and the cell pellet was resuspended in 3ml of RBC lysis buffer 
(eBiosciences) at 37ºC and incubated at room temperature for 6 minutes. 12ml of RPMI 
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was added to the suspension then centrifuged at 1,200 rpm for 10 minutes. The 
supernatant was removed and the cell pellet was resuspended in PBS (Corning 
Incorporated) with 1% Bovine Serum Albumin (BSA – Fraction V) for cell sorting. 
 
Fluorescence-activated cell sorting (FACS) Cell Sorting 
The prepared splenocytes suspension was stained with an antibody cocktail 
containing live/dead indicator (Zombie aqua), hematopoietic cell marker CD45, B cell-
specific markers CD19 and CD20, and the T cell-specific marker CD4. The cells were 
then washed and resuspended in 3ml of FACS buffer (PBS with 1% BSA). A total of 
400,000 B and T lymphocytes were sorted into 10ml of RPMI medium. The sorted cells 
were centrifuged at 1,200 rpm for 10 minutes, and the pellets were resuspended in RPMI 
medium at 50,000 cells per 50µl (106 cells/ml) for osteoclastogenesis assays. 
 
RAW cell preparation 
An adherent mouse leukemic monocyte/macrophage cell line, RAW 264.7, was 
harvested from culture by aspirating media and adding 500µl of PBS-based non-
enzymatic cell detaching buffer. The cell suspension was incubated for 5 minutes at 37ºC. 
The cells were transferred to a 15ml conical tube with 4.5ml Dulbecco’s Modified Eagle 
Medium High Glucose (4.5g/L) (DMEM) with 10% FBS, 1% penicillin/streptomycin and 
4.0mM L-glutamate, and centrifuged at 1,200 RPM for 10 minutes. The supernatant was 
removed and the cell pellet was resuspended in Minimum Essential Medium Eagle – 
Alpha Modification (Modified MEM) with 10% FBS, 1% penicillin/streptomycin and 
   
8 
 
4.0mM L-glutamate. The cells were counted using a hemocytometer. The cell suspension 
was diluted to a concentration of 1x104 cells/ml using Modified MEM. The cell 
suspension was transferred to a 96-well flat bottom plate  at 100 cells/well. Recombinant 
RANKL was added for pre-stimulation to the RAW cells after 6 hours of incubation. 
 
B and T cell Stimulation 
For single culture experiments, 1000 of each unstimulated B and T cells were 
added to each well of RANKL-primed RAW cells. For B and T co-culture experiments, 
B or T cells were added at 10:1 ratio according to the experimental setting. 
RAW cells only were the negative control and RAW cells primed with 
recombinant RANKL was the positive control  For cultures containing stimulated B cells, 
the B cells were treated with 10µg/ml of E. coli lipopolysaccharides (Invivogen) for 24 
hours then washed with RPMI three times prior to transfer to remove LPS prior to 
addition to RAW cultures. For cultures containing stimulated T cells, the T cells were 
treated with αCD3/28 antibody-coated Dynabeads (Life Technology) for 24 hours prior 
to addition to RAW cultures. Supernatants from all cultures were collected for RANKL 
enzyme-linked immunosorbent assay (ELISA) after 24hrs incubation. Direct RANKL 
protein measurements in cell supernatants by ELISA  were below the level of detection. 
 
Pit formation on Dentin Plates 
A second independent set of assays were performed on 96-well format dentin 
plates for pit formation analysis, a functional measure of the ability of immune cells to 
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support osteoclastogenesis. 96-well flat bottom plates were used for cell culture for both 
single and co-culture of B and T lymphocytes. Cells were incubated in these plates 
(stimulated or unstimulated) then transferred to a second assay performed on 96-well 
dentin plates (Corning, CLS3988). Anti-RANKL antibody was added to inhibit the 
interaction between RANK and RANKL therefore osteoclastic 
activity/osteoclastogenesis which serves as the negative control. The dentin plates serve 
as a mineralized surface that osteoclasts, if present, would degrade the dentin coating and 
create a zone of clearance. RAW cells were allowed to adhere to the plates during an 
incubation period of at least 6 hours. Pre-stimulation of the seeded cells were completed 
by incubating with RANKL for two days to generate pre-osteoclasts. The medium was 
changed to remove the added RANKL. B and T cells were introduced as outlined below 
and incubated for three days to determine the development of functional osteoclasts from 
the pre-osteoclasts. These plates were used to quantify osteoclastic activity.  
 
Tartrate-resistant acid phosphatase (TRAP) staining for osteoclast formation 
 After 1000 RAW cells were plated on the 96-well flat bottom plate, 100µl of 
murine RANKL in modified MEM(100ng/ml) was added to each well (final 
concentration of RANKL was 50ng/ml). Different combinations of B and T cells were 
added to each well according design (table 1). Media was replenished every other day by 
removing 100 µl medium and adding 100µl fresh medium containing the same 
concentration of murine RANKL. After 5 to 7 days of incubation, the cells were stained 
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using a Tartrate-resistant acid phosphatase (TRAP) stain to quantify the presence of 
osteoclasts 
 
Pit Assay Analysis 
Dentin wells were treated with 1:4 bleach and von Kossa stain to show pit 
surface. The cleared areas that indicate osteoclastogenic function show up as dark under 
bright field. Digital images were taken with a Nikon camera. All dentin plate images 
were taken at a standardized size. The cleared areas were marked with red (RGB 255, 0, 
0) using Adobe Photoshop by two operators blinded of the experimental groups. The 
resulting labeled images were processed through a customized software written in Java 
that counts the number of RGB (255, 0, 0) pixels (Jerry Chiu, unpublished). 
Statistical analysis of the data was performed by GraphPad Prism using 1-way 
ANOVA with Tukey post-hoc test for corrections for multiple comparisons. A p-value of 
≤0.05 was considered statistically different.  
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Figure 2. Summary of experimental design for TRAP stain and Pit assay.  
White boxes show TRAP protocol, gray boxes show PIT assay protocol, and Black boxes 
show addition of B and T cells in both experiments.  
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RESULTS 
Metabolic status of model animal 
Mice were fed with either low fat diet (LFD) or high fat diet (HFD) for 16 weeks. 
Body weight and fasting glucose level were measured and intra-peritoneal glucose 
tolerance test (IPGTT) was performed at the 15th week of diet. HFD mice was 
significantly heavier and had higher fast glucose level. IPGTT showed a slower glucose 
clearance over 120 minutes in HFD compared to LFD mice. These results indicate 
impaired glucose homeostasis, which in turn confirms the diabetes-like phenotype in 
HFD mice. 
 
  
Figure 3. Body weight, fasting blood glucose levels, and intra-peritoneal glucose 
tolerance test of mice on LFD and HFD. 
Time = 15th week of diet (n = 11 *p<0.05). 
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Splenocyte sorting 
Splenocytes harvested from LFD and HFD mice were sorted for into four groups 
of cells: B lymphocytes from LFD mice, B lymphocytes from HFD mice, T lymphocytes 
from LFD mice, and T lymphocytes from HFD mice (Figure 4).  
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Figure 4. Flow cytometry gating.  
(A) Lymphocytes. Bottom left cluster represents debris and top right scattered points 
represent dead cells. (B, C) Single cells. Double discrimination based on side scatter and 
forward scatter excluded cells stuck together. (D) Live cells. Zombie NIR live-dead stain 
used to exclude dead cells. (E) CD45+ Leukocytes. Macrophages were excluded using 
CD11b+ surface marker. (F) CD4+ T helper cells and CD19+ B cells were purified from 
gates shown.  We obtained the expected B:T ratio of approximately 1:4.5 from C57BL/6 
mouse splenocytes 
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Tartrate-Resistant Acid Phosphatase (TRAP) staining of osteoclasts 
Cells were plated in single culture and co-culture combinations as summarized 
(Table 1).  Number of osteoclasts were measured following TRAP stain. RAW cells 
alone was used as control and background for TRAP staining (Figure 5A). Positive 
control was represented with RAW cells stimulated with RANKL (Figure 5B). Negative 
control was represented with RAW cells treated with RANKL and anti-RANKL (Figure 
5C). TRAP seeding conditions which show osteoclastic activity in stimulated B cells 
from LFD mice(Figure 5D). Direct RANKL protein measurements in cell supernatants by 
ELISA were below the level of detection. 
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RAW 
cells 
RANKL 
Anti-
RANKL 
B cells T cells 
      
       
        
     Unstimulated, Lean  
     
Unstimulated, 
Obese 
 
      
Unstimulated, 
Lean 
      
Unstimulated, 
Obese 
     Stimulated, Obese  
      Stimulated, Obese  
     Stimulated, Lean  
      Stimulated, Lean  
      
Stimulated, 
Obese 
       
Stimulated, 
Obese 
      Stimulated, Lean 
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       Stimulated, Lean 
     Stimulated, Lean Stimulated, Lean 
     Stimulated, Lean 
Unstimulated, 
Lean 
     Unstimulated, Lean Stimulated, Lean 
     Stimulated, Obese 
Stimulated, 
Obese 
     Stimulated, Obese 
Unstimulated, 
Obese 
     
Unstimulated, 
Obese 
Stimulated, 
Obese 
     Stimulated, Lean 
Stimulated, 
Obese 
     Stimulated, Obese Stimulated, Lean 
Table 1. All culture combinations for B and T cells.  
White cells indicate cultures of single purified cell types. Shaded cells indicate co-
cultures of purified B and T cells from mice fed as indicated. 
 
TRAP staining analysis was able to demonstrate presence of osteoclastic activity. 
However, quantifying the osteoclastic activity was difficult because of high background 
noise due to some non-specificity in our staining. Analysis of the measurements based on 
TRAP staining showed no significant differences in stimulated and unstimulated B and T 
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cells (Figure 6). We therefore pursued pit forming assays on dentin plates with von Kossa 
staining as a more accurate measurement of osteoclastic activity.  
 
 
Figure 5. Magnified images of TRAP staining.  
(A) Background represented by RAW cells. (B) Positive control, represented by RAW 
cells stimulated with RANKL twice: once to form pre-osteoclasts, and a second time for 
full differentiation to osteoclasts. (C) Negative control represented by RAW cells treated 
with RANKL and anti-RANKL. (D) TRAP staining of stimulated B cells from lean 
(LFD) mice. Arrow indicates multinucleate osteoclasts. 
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Figure 6. TRAP stained osteoclasts in test groups.  
White bars show LFD groups and gray bars show HFD groups. Significant differences 
were calculated using a one-way ANOVA. Data presented as mean ± standard error, 
p<0.05. Analysis of trap data showed no significant differences in stimulated and 
unstimulated B and T cells 
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Application of digital tools in routine laboratory tests 
Previous protocol for measuring dentin plate pit formation area was primarily 
manual and labor-intensive. I developed a new approach to processing such data as part 
of my project to improve the efficiency for the repetitive and mechanical tasks and 
compiling measurements without affecting the quality of measurements. The unprocessed 
digital micro-photographs of the dentin plates were analyzed manually to identify the 
area of clearance and labeled using Adobe Photoshop. Taking advantage of the image 
processing software I developed offered a much higher user-friendliness than common 
research lab tools such as ImageJ from National Institute of Health (NIH). This software 
allowed the simple tasks of identifying area of clearance and coloring the area with an 
arbitrary color to be completed with ease.  
I created a custom-made software designed to process the resulting digital 
photographs in the Java programming language. The central algorithm used processed the 
digital image as a two-dimensional array of pixels. Each pixel was tested for its RGB 
(Red, Green, Blue) value. As the algorithm cycles through the array, each pixel with our 
specified RGB will contribute to size count of the clearance area. At the end of the 
algorithm, the output will consist of two numbers: the total number of pixels, and the 
number of pixels of the specified RGB value. Then, by combining these two numbers and 
the condition of the digital photograph, the actual area of clearance can easily be 
calculated. The software automatically process the entire collection of digital photos, 
obtains the data, then further compiles the collected information into Microsoft Excel 
format for later statistical analysis. 
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Pit Assay on Dentin Plate 
Representative sample for analysis of pit formation area is shown in Figure 7.  
Results from pit assay on dentin plate for osteoclastogenesis are shown in Figure 8.  
Single cultures yielded no difference between any of the test groups. No 
difference in the promotion of osteoclastogenesis, as measured by pit formation area was 
among B and T cells from LFD and HFD mice, regardless of stimulation. The only 
statistically significant difference was noted between RAW cells (pre-osteoclast negative 
control) and RAW pre-osteoclasts with RANKL added (positive control). There is a trend 
of unstimulated lymphocytes producing higher pit area formation compared to stimulated 
lymphocytes, which is inconsistent with the current understanding that stimulation will 
increase RANKL production.  
 
 
Figure 7. Representative image of pit formation on dentin plate analysis.  
(A) Original digital photograph of 96-well coated with dentin. Cleared areas indicate 
osteoclastic activity. (B) Cleared areas labeled using Photoshop (Adobe) with RGB value 
(255, 0, 0)  then measured by customized software (Jerry Chiu). 
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Figure 8. Pit areas from pit assay on dentin plate for osteoclastogenesis.  
RAW cells only (Control), pre-osteoclast RAW cells stimulated with RANKL (Positive 
control). Pit area represents osteoclastic activity which indicates osteoclastogenesis. 
Stimulation of lymphocytes as described in materials and methods. No significant 
differences noted test groups, via two-way ANOVA. Data presented as mean ± SEM; *P 
< 0.05.  
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anti-RANKL (Figure. 9) . Furthermore, we detected no differences between RAW pre-
osteoclast cells stimulated with RANKL only and RAW pre-osteoclast cells stimulated 
with RANKL and isotype antibodies (Figure. 9). 
 
 
Figure 9. Inhibition of RANKL by anti-RANKL antibody.  
Treatment with anti-RANKL significantly reduces pit area compared to corresponding 
groups. Significant difference calculated by one-way ANOVA. Data presented as mean ± 
SEM; *P < 0.05.  
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Single and Co-cultures of stimulated and unstimulated B and T lymphocytes 
Previous work from our lab showed B cells support T cell inflammation in T2D 
[26]. To test whether lymphocyte cross-talk also  potentiates osteoclastogenesis in T2D, 
we co-cultured B and T cells in the presence or absence of stimulation prior to adding 
them to RAW pre-osteoclast cultures. We determined osteoclastic activity through 
RANKL production and the pit areas in these co-cultures (Figure 10).  
Stimulated B cells from LFD mice produced the highest osteoclastic activity 
when co-cultured with stimulated T cells from LFD mice. This level of activity was 
significantly higher than the osteoclastic activity produced from the co-culture of their 
counterparts from HFD mice. Co-cultures of B cells and T cells from lean mice 
significantly increased osteoclastogenesis relative to other cell combinations, as measured 
by an increase in pit area . No significant difference amongst the unstimulated co-cultures 
was noted. The data suggest that T lymphocytes have some effect on osteoclastic activity 
when co-cultured with B lymphocytes (or vice versa) within lean hosts suggesting non-
redundant RANKL production relative to single cell type cultures. 
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Figure 10. Single and co-cultures of stimulated and unstimulated B and T 
lymphocytes.  
Co-culture ratios are 1000:100 cells shown as written. Significant difference calculated 
by one-way ANOVA. Data presented as mean± SEM; *P < 0.05. “L” in LB and LT 
groups indicate “lean”, as in the hosts were fed with low fat diet. “O” in OB and OT 
groups indicate “obese”, as in the hosts were fed with high fat diet. “B” and “T” indicates 
B or T cells. 
   
26 
 
DISCUSSION 
Type 2 diabetes and Periodontitis 
Our long-term goals are to define the mechanisms that potentiate periodontitis in 
type 2 diabetes and to use this knowledge to develop methods to control inflammatory 
complications in patients with type 2 diabetes. B cells have a critical role in experimental 
type 2 diabetes-associated periodontitis in our animal model: the type 2 diabetes-
associated changes in B cells were shown to be required for osteoclastogenesis and 
therefore periodontal bone loss in a diabetic host. Furthermore, without B cells, T cells 
cannot drive periodontal bone loss in diabetic hosts [17]. Our published findings in 
obese/T2D mice contrasted with evidence showing T cells promote periodontal bone loss 
in lean hosts [27]. To further explore this relationship, we tested the hypothesis that type 
2 diabetes-associated changes in B and/or T lymphocytes leads to up-regulation of 
osteoclastogenesis and thereby periodontal bone loss. 
The rationale for studying the level of bone resorptive osteoclasts stems from 
using periodontal bone loss as the primary parameter for determining the severity of 
periodontitis. Osteoclasts are the primary cells known for bone resorption. Their level of 
activity depends on their quantity, and osteoclastogenesis is regulated through the 
RANK/RANKL/OPG system. With upregulated level of RANKL, the system favors 
osteoclastogenesis and thereby increases the osteoclastic activity. Both B and T cells are 
major sources of RANKL [24]. These cells’ expression of RANKL can be altered by 
inflammatory mediators which is altered in the diabetic conditions via the accumulation 
of AGE and their interaction with RAGE [28]. Therefore, by comparing B and T cells 
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from diabetic and metabolically normal mice and studying the downstream effect on 
osteoclastic activity, we may gain further insight into the relationship between diabetes 
and periodontal bone loss. 
From this study, when the groups of lymphocytes were tested individually, i.e. 
single cell cultures where RAW cells were cultured with B cells only or with T cells only, 
no difference was detected among the experimental groups. No difference was measured 
in terms of osteoclastogenesis regardless of metabolic status (HFD vs LFD), stimulation 
vs not, or between B and T cells. This lack of difference may be interpreted as diabetes 
does not impact the severity of bone resorption. This finding is inconsistent with the 
current consensus that the periodontal destruction is more severe in diabetic individuals 
compared to a metabolically healthy individuals, which would have predicted cells from 
HFD hosts to have increased level of osteoclastic activity. Furthermore, comparing the 
levels of osteoclastic activity of the experimental groups to the positive control, showed 
no statistical difference. Given that the level of RANKL directly affects 
osteoclastogenesis, I conclude that the concentrations of bioactive RANKL are similar 
among all the groups, excepting expected results from the controls.  
Our data clearly show that metabolic status and/or stimulation with 
lipopolysaccharide or αCD3/28 antibody do not affect RANKL production as measured 
by downstream osteoclastogenesis. However, this conclusion countered our original 
model where the latter group would have been predicted to have the highest activity, and 
also counters the current understanding of changes associated with diabetes regarding 
inflammation[7] and osteoimmunology[1]. This discrepancy may be attributed to our ex 
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vivo approach that may not have accurately recapitulate the biology of the in vivo 
system- our tissue culture well and dentin plates are quite different compared to the oral 
cavity, and the cellular components and interplay in vivo are more complex in the oral 
cavity. Although it is formally possible that lymphocyte RANKL play no role in T2D-
associated periodontal disease, the abundance of evidence supporting this idea indicate 
other approaches may be needed to test our hypothesis. Therefore, it may be prudent to 
repeat the single culture experiments before drawing conclusions. 
B cells were previously shown to play a significant role in periodontal bone 
resorption in vivo[17]. In the current experiment, B cells were co-cultured with T cells to 
observe for any changes. The co-culture with stimulated B and T cells from HFD mice 
demonstrated higher osteoclastogenesis compared to most other groups, second only to 
the co-culture with stimulated B and T cells from LFD mice. The higher 
osteoclastogenesis from cells from HFD mice was consistent with current evidence and in 
agreement with our proposed model, but the highest osteoclastogenesis from cells from 
LFD mice was unexpected. While evidence suggests T cells to promote 
osteoclastogenesis in lean hosts, which is consistent with this finding, diabetic individuals 
have an exaggerated inflammatory reaction and more severe bone resorption, therefore 
osteoclastogenesis is expected to be greater in diabetic hosts than in lean hosts. This may 
suggest unknown interactions from T cells within metabolically normal hosts. 
In a recent review article examining the relationship and interactions between 
diabetes mellitus and periodontitis, the ‘two-hit’ model was suggested [5]. In this model, 
which offers one explanation for the pathogenesis of accelerated periodontal destruction 
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in patients with diabetes mellitus, both exaggerated inflammatory response and 
destruction and impaired repair are considered. Hyperglycemia from poorly managed 
diabetes results in accumulation of advanced glycation end-products (AGE) which 
interact with their receptors (RAGE). This interaction leads to exaggerated inflammatory 
response to the bacterial challenge such as the dental plaque in the gingival sulcus. Then, 
increased destruction results from the upregulated expression of RANKL that contribute 
to osteoclastogenesis and therefore bone resorption [29]. Our findings from the current 
study is consistent with this proposal and adds to it with further details into the roles of B 
and T lymphocytes in this interactions depending on the host’s diabetes condition. Future 
focus on impacts of the AGE/RAGE system in lymphocytes will be important towards 
testing this possibility. 
The second ‘hit’ in the 2-hit model involves impaired repair. This stems from the 
increased apoptosis of bone-lining cells, which result in impaired bone formation 
following bone resorption and contribute to the net loss of bone [30] [29]. This effect on 
bone-lining cells may be attributed to the activity from RAGE. In diabetic mice, 
inhibition of RAGE can improve healing of excisional wounds [31]. Also, it was shown 
in a mice skull model with cultured osteoblasts that AGE-RAGE interactions contribute 
to delayed bone healing and RAGE mediates apoptosis of osteoblasts [32] [33]. 
Therefore, it may be reasonable to anticipate inhibition of AGE-RAGE interaction to 
improve the periodontitis severity. A study on rats treated with aminoguanidine which 
inhibits the AGE-RAGE interaction [34] showed reduced periodontal bone loss during 
experimental periodontitis induction, this treatment did not result in a different bone level 
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at the conclusion of the study when compared with treatment using normal saline. 
However, it is unclear whether the model animals were in a condition that resembled 
uncontrolled diabetes, which leaves a possible opportunity to further apply our existing 
animal model, as we did not test the importance of B cells in repair of periodontal lesions. 
Concluding the above information, possible future opportunities to explore are: 
1. Does AGE-RAGE interaction affect the level of RANKL and thus 
osteoclastogenesis in our HFD/LFD mice models? 
2. Does inhibition of AGE-RAGE interaction affect the level of RANKL and thus 
osteoclastogenesis in our HFD/LFD mice models? 
3. Does inhibition of AGE-RAGE interaction reduce the severity of periodontal 
bone loss in our HFD/LFD mice model?  
 
Application of digital tools in routine laboratory tests 
By automating pit formation quantification, not only were we able to greatly 
improve the efficiency and reduce the man-hours greatly, the concerns for human errors 
in entering and compiling numbers were completely eliminated (assuming that all the 
samples were labeled correctly). Such digital tool has demonstrated its potential to 
improve the research laboratory workflow and quality of work in our study. Future 
development may be warranted. A possible development for similar applications that is 
within reach is to include an edge-detection algorithm to automatically distinguish the 
area of interest from the background (such as dentin clearance) and create the accurate 
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border, which can further improve the efficiency of data analysis by removing the need to 
color-code manually using other image processing software.  
The implication is that it is possible to remove human involvement or at least 
greatly reduce human labor in the repetitive and mechanical tasks, and at the same time 
minimizing human bias and error. The value of human labor is in creating and critical 
thinking, such as synthesizing evidence, designing experiments and interpreting the data, 
and the greater utilization of our computer tools will allow scientists to maximize these 
irreplaceable abilities. 
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